Together, these data suggest that alterations in ARID3a levels during early hematopoiesis in SLE patients could have profound effects on mature cell phenotypes and lineage pathways, as shown in Figure 4, even before known B cell tolerance checkpoints occur. Here, ARID3A is linked to systemic lupus erythematosus.